GWM
INSP icon

Geneos Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Geneos Wealth Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$519 – 2820
2025
Q2 		$519 Buy
+4
New +$580 ﹤0.01% 3106
2023
Q4 		– Sell
-3
Closed -$595 – 2134
2023
Q3 		$595 Buy
+3
New +$757 ﹤0.01% 2083
2020
Q2 		– Sell
-300
Closed -$16K – 2590
2020
Q1 		$16K Hold
300
– – ﹤0.01% 1603
2019
Q4 		$22K Buy
+300
New +$19.3K ﹤0.01% 1637

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geneos Wealth Management's INSP Position: Q3 2025 in Review

Geneos Wealth Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 4 shares — an estimated $519 sold.

Geneos Wealth Management first reported a position in INSP in Q4 2019 and held it in 4 quarters. The position peaked at $22K in Q4 2019. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Geneos Wealth Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 4 Inspire Medical Systems shares in Q3 2025, an estimated $519.
  • Geneos Wealth Management first reported a position in Inspire Medical Systems in Q4 2019 and held it in 4 quarters.
  • Geneos Wealth Management's Inspire Medical Systems position peaked at $22K in Q4 2019.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.